186 results on '"Sarris, Andreas H."'
Search Results
2. Real-Time Polymerase Chain Reaction of Genomic DNA for Quantitation of t(14;18)
3. CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)
4. Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination
5. Very high levels of soluble CD30 recognize the patients with classical Hodgkinʼs lymphoma retaining a very poor prognosis
6. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia
7. A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas
8. High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
9. Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkinʼs Lymphoma
10. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria
11. CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin’s Disease: Associations With Presenting Features and Clinical Outcome
12. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma
13. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
14. Non-Hodgkinʼs Lymphoma Affecting the Testis: Is It Curable with Doxorubicin-Based Therapy?
15. Primary Cutaneous Non-Hodgkin’s Lymphoma of Ann Arbor Stage I: Preferential Cutaneous Relapses but High Cure Rate With Doxorubicin-Based Therapy
16. Real-Time 5′ → 3′ Exonuclease-Based PCR Assay for Detection of the t(11;14)(q13;q32)
17. Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial
18. Paclitaxel plus high-dose cyclosphosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
19. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
20. Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone
21. Differential Expression of BCL-2 Family Proteins in ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma of T/Null-Cell Lineage
22. Cyclosporine treatment of refractory T-cell lymphomas
23. Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma
24. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis
25. Detection of t(2;5)(p23;q35) Translocation by Long-Range PCR of Genomic DNA
26. Real-Time Polymerase Chain Reaction of Genomic DNA for Quantitation of t(14;18)
27. Long Term Results Of a Phase 2 Study Of Vincristine Sulfate Liposome Injection (Marqibo®) Substituted For Non-Liposomal Vincristine In CHOP With Or Without Rituximab For Patients With Untreated Aggressive Non-Hodgkin’s Lymphomas
28. Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy
29. Primary parotid lymphoma: the effect of International Prognostic Index on outcome
30. Amplification of genomic DNA demonstrates the presence of the t (2; 5)(p23; q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
31. Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma
32. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy
33. First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
34. CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)
35. Blastoid Mantle Cell Lymphoma (MCL): 5-yr Failure-Free Survival (FFS) Rate of 50%, without Failures after 2.5 Years Following Treatment with Rituximab (R)-HyperCVAD Alternating with R-Methotrexate/Cytarabine (M/A).
36. Primary Diffuse Large B-Cell Lymphoma of the Testis (PTL): A Prospective Study of Rituximab (R)-CHOP with CNS and Contralateral Testis Prophylaxis. Results of the IELSG 10 Study.
37. Prospective Management of Primary Testicular Lymphoma (PTL) with Doxorubicin-Based Chemotherapy, Prophylactic Intrathecal (IT) Methotrexate and Radiotherapy (RT), but without Rituximab: Results from IELSG.
38. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia
39. Rituximab Plus Hypercvad (R-HCVAD) Alternating with Rituximab Plus High-Dose Methotrexate-Cytarabine (R-M/A) in Untreated Mantle Cell Lymphoma (MCL): Prolonged Follow-Up Confirms High Rates of Failure-Free Survival (FFS) and Overall Survival (OS).
40. Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy
41. Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease
42. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation
43. Overexpression of Mcl-1 in Anaplastic Large Cell Lymphoma Cell Lines and Tumors
44. CD4− CD8− `Double-Negative' Cutaneous T-Cell Lymphomas Share Common Histologic Features and an Aggressive Clinical Course
45. Quantitative Real-Time Polymerase Chain Reaction for Detection of Circulating Cells with T(14;18) in Volunteer Blood Donors and Patients with Follicular Lymphoma
46. Non-Hodgkin's Lymphoma Involving the Gynecologic Tract: A Review of 88 Cases
47. Protein Aggregation Mediated by Cysteine Oxidation During the Stacking Phase of Discontinuous Buffer SDS-PAGE
48. Human Recombinant Interferon-Inducible Protein-10: Intact Disulfide Bridges Are Not Required for Inhibition of Hematopoietic Progenitors and Chemotaxis of T Lymphocytes and Monocytes
49. Anaplastic Lymphoma Kinase (ALK) is not Expressed in Hodgkin's Disease: Results with ALK-11 Antibody in 327 Untreated Patients
50. Hodgkin's Disease in Patients Infected with Human Immunodeficiency Virus: Frequency, Presentation and Clinical Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.